24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
UroGen
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
14:36
Iron Dome and Iron Beam maker Rafael moves closer to a possible IPO
14:20
Weapons as strategy: Israel’s defense industry steps into a larger global role
09:09
CTech’s Book Review: What strategy really is and why so many organizations get it wrong
08:20
British Ambassador to Israel, Simon Walters: “If you build in Britain, we will back you”
More stories
Buzz
Most popular
Daily
Weekly
1
Huang declares Israel Nvidia’s “second home” with record-breaking campus investment
2
Cyera raises $400 million at $9 billion valuation in Blackstone-led round
3
Vega raises $120 million Series B as two-year-old cyber startup hits $700 million valuation
4
Dell acquires AI data-infrastructure startup Dataloop in $120 million all-cash deal
5
“The acquisition of Armis marks a clear entry by ServiceNow into cybersecurity”
More news
UroGen
5 stories about UroGen
”Exits are not a Strategy. I Never put up a ‘For Sale’ Sign”
23.05.20
|
Sophie Shulman and Golan Hazani
Arie Belldegrun, chairman of UroGen Pharma, talks about catching Covid-19 and gaining FDA approval in the midst of a global pandemic
Johnson & Johnson Subsidiary Janssen Partners With Sustained Drug Release Company UroGen
24.04.19
|
CTech
The two companies will collaborate on the research of a “therapeutic area of mutual interest”
Sustained Drug Release Company UroGen Aiming to Raise $150 Million on Nasdaq
24.01.19
|
Lilach Baumer
Goldman Sachs & Co. LLC, JP Morgan, and Jefferies are the joint bookrunners for the offering
Sustained Drug Release Company UroGen Submits New Drug Application to FDA
12.07.18
|
Amir Rosenbaum
Kite Pharma founder Arie Belldegrun is the chairman of Israel-based UroGen, which focuses mainly on cancer treatment and urinary tract infections
Allergan Partners with Urine Incontinence Treatment Company
08.11.17
|
Lilach Baumer
Allergan is conducting clinical trials for a Botox-based bladder treatment, using a sustained release gel developed by Israel-based UroGen